These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 16126181)

  • 1. Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats.
    Bruijnzeel AW; Markou A
    Brain Res; 2005 Oct; 1058(1-2):91-100. PubMed ID: 16126181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats.
    Bruijnzeel AW; Markou A
    Neuropharmacology; 2004 Sep; 47(4):572-9. PubMed ID: 15380374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
    Harrison AA; Gasparini F; Markou A
    Psychopharmacology (Berl); 2002 Feb; 160(1):56-66. PubMed ID: 11862374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
    Jonkman S; Markou A
    Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine signaling through D1-like versus D2-like receptors in the nucleus accumbens core versus shell differentially modulates nicotine reward sensitivity.
    Laviolette SR; Lauzon NM; Bishop SF; Sun N; Tan H
    J Neurosci; 2008 Aug; 28(32):8025-33. PubMed ID: 18685027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of D1/D2 dopamine receptors in the CA1 region of the rat hippocampus in the rewarding effects of morphine administered into the ventral tegmental area.
    Esmaeili MH; Kermani M; Parvishan A; Haghparast A
    Behav Brain Res; 2012 May; 231(1):111-5. PubMed ID: 22426507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuro-anatomic mapping of dopamine D1 receptor involvement in nicotine self-administration in rats.
    Hall BJ; Slade S; Allenby C; Kutlu MG; Levin ED
    Neuropharmacology; 2015 Dec; 99():689-95. PubMed ID: 25797492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors.
    David V; Besson M; Changeux JP; Granon S; Cazala P
    Neuropharmacology; 2006 Jun; 50(8):1030-40. PubMed ID: 16580026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin A induced antinociception in the ventral tegmental area involves D1 and D2 receptors in the nucleus accumbens.
    Yazdi-Ravandi S; Razavi Y; Haghparast A; Goudarzvand M; Haghparast A
    Pharmacol Biochem Behav; 2014 Nov; 126():1-6. PubMed ID: 25179164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orexin A in the ventral tegmental area induces conditioned place preference in a dose-dependent manner: involvement of D1/D2 receptors in the nucleus accumbens.
    Taslimi Z; Arezoomandan R; Omranifard A; Ghalandari-Shamami M; Riahi E; Vafaei AA; Rashidy-Pour A; Haghparast A
    Peptides; 2012 Oct; 37(2):225-32. PubMed ID: 22885169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area.
    Hildebrand BE; Panagis G; Svensson TH; Nomikos GG
    Neuropsychopharmacology; 1999 Oct; 21(4):560-74. PubMed ID: 10481840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of insular cortex D₁ and D₂ dopamine receptors in nicotine self-administration in rats.
    Kutlu MG; Burke D; Slade S; Hall BJ; Rose JE; Levin ED
    Behav Brain Res; 2013 Nov; 256():273-8. PubMed ID: 23948214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
    Paterson NE; Balfour DJ; Markou A
    Eur J Neurosci; 2007 May; 25(10):3099-108. PubMed ID: 17561823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to nicotine increases dopamine receptor content in the mesocorticolimbic pathway of rat dams and offspring during lactation.
    Pinheiro CR; Oliveira E; Manhães AC; Fraga MC; Claudio-Neto S; Younes-Rapozo V; Lotufo BM; Moura EG; Lisboa PC
    Pharmacol Biochem Behav; 2015 Sep; 136():87-101. PubMed ID: 26219213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine.
    Reisi Z; Bani-Ardalan M; Zarepour L; Haghparast A
    Pharmacol Biochem Behav; 2014 Mar; 118():16-21. PubMed ID: 24418216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
    Bruijnzeel AW; Zislis G; Wilson C; Gold MS
    Neuropsychopharmacology; 2007 Apr; 32(4):955-63. PubMed ID: 16943772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects.
    Tan H; Bishop SF; Lauzon NM; Sun N; Laviolette SR
    Neuropharmacology; 2009 Mar; 56(4):741-51. PubMed ID: 19133278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged nicotine exposure does not alter GABA(B) receptor-mediated regulation of brain reward function.
    Paterson NE; Bruijnzeel AW; Kenny PJ; Wright CD; Froestl W; Markou A
    Neuropharmacology; 2005 Dec; 49(7):953-62. PubMed ID: 16005474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of ventral tegmental area dopamine neuronal activity in nicotine withdrawal rats.
    Liu ZH; Jin WQ
    Neuroreport; 2004 Jun; 15(9):1479-81. PubMed ID: 15194878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of ventral tegmental area dopamine receptors inhibit nicotine-induced anxiogenic-like behavior in the central amygdala.
    Zarrindast MR; Eslahi N; Rezayof A; Rostami P; Zahmatkesh M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Mar; 41():11-7. PubMed ID: 23178824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.